Defibrillation lead placement using a transthoracic transatrial approach in a case without transvenous access due to lack of the right superior vena cava

Documenti analoghi

• Importance of exercise testing shortly after subcutaneous implantable cardioverter-defibrillator implantation in patients with Brugada syndrome – The first case of associated inappropriate shock in Japan
  di: Ishibashi, Kohei, et al.
  Pubblicazione: (2017)
• Transvenous defibrillator implantation in a patient with persistent left superior vena cava
  di: Vijayvergiya, Rajesh, et al.
  Pubblicazione: (2013)
• Subcutaneous and transvenous implantable cardioverter defibrillator in high-risk long-QT syndrome type 3 associated with Val411Met mutation in SCN5A
  di: Yokoyama, Yasuhiro, et al.
  Pubblicazione: (2020)
• T-wave oversensing during drug challenge test after subcutaneous implantable cardioverter-defibrillator implantation in a patient with Brugada syndrome
  di: Kamakura, Tsukasa, et al.
  Pubblicazione: (2016)
• Risk factors associated with bleeding after multi antithrombotic therapy during implantation of cardiac implantable electronic devices
  di: Ishibashi, Kohei, et al.
  Pubblicazione: (2016)